Metformin: effects on micro and macrovascular complications in type 2 diabetes

Keyphrases

• Type 2 Diabetes Mellitus (T2DM) 100%
• Metformin 100%
• Vascular Complications 100%
• Atherosclerotic Lesions 14%
• Insulin Resistance 14%
• Type 2 Diabetic Patients 14%
• Inflammatory Cytokines 14%
• Diabetes 14%
• Obesity 14%
• Vasculature 14%
• Antihyperglycemic 14%
• Monocyte Adhesion Molecules 14%
• Type 2 Diabetes Prevention 14%
• Myocardial Infarction 14%
• Vasoprotective Effect 14%
• Inflammatory Monocytes 14%
• Blood Glucose Reduction 14%
• Glycation 14%
• Endothelial Function 14%
• Healthcare Database 14%
• Carotid Intima-media Thickness (cIMT) 14%
• Dyslipidemia 14%
• Surrogate Measures 14%
• Hyperinsulinemia 14%
• Atherothrombotic Risk 14%
• Antithrombotic Effect 14%
• Retrospective Analysis 14%
• Microvasculature 14%
• Anti-atherogenic Effect 14%

Medicine and Dentistry

• Maturity Onset Diabetes of the Young 100%
• Glycon 100%
• Diabetes 14%
• Diabetes Mellitus 14%
• Clinical Study 14%
• Vascularity 14%
• Cell Adhesion Proteins 14%
• Insulin Resistance 14%
• Myocardial Infarction 14%
• Blood Glucose 14%
• Antithrombotic 14%
• Atherogenesis 14%
• Hyperinsulinemia 14%
• Intima-Media Thickness 14%
• Glycation 14%
• Endothelial Function 14%
• Dyslipidemia 14%
• Inflammatory Cytokine 14%
• Microvessel 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Metformin 100%
• Cytokine 14%
• Insulin Resistance 14%
• Diabetes Mellitus 14%
• Heart Infarction 14%
• Cell Adhesion Proteins 14%
• Atherogenesis 14%
• Anticoagulant Agent 14%
• Dyslipidemia 14%
• Clinical Study 14%
• Hyperinsulinemia 14%